000 | 01350 a2200337 4500 | ||
---|---|---|---|
005 | 20250518084538.0 | ||
264 | 0 | _c20210125 | |
008 | 202101s 0 0 eng d | ||
022 | _a2045-8827 | ||
024 | 7 |
_a10.1002/mbo3.1005 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLaBreck, Patrick T | |
245 | 0 | 0 |
_aFitness costs associated with carriage of a large staphylococcal plasmid are reduced by subinhibitory concentrations of antiseptics. _h[electronic resource] |
260 |
_bMicrobiologyOpen _c04 2020 |
||
300 |
_ae1005 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 |
_aBacterial Proteins _xgenetics |
650 | 0 | 4 |
_aChlorhexidine _xpharmacology |
650 | 0 | 4 |
_aDisinfectants _xpharmacology |
650 | 0 | 4 |
_aDrug Resistance, Multiple, Bacterial _xgenetics |
650 | 0 | 4 |
_aEnoyl-(Acyl-Carrier-Protein) Reductase (NADH) _xgenetics |
650 | 0 | 4 |
_aGenetic Fitness _xgenetics |
650 | 0 | 4 |
_aMembrane Transport Proteins _xgenetics |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 |
_aPlasmids _xgenetics |
650 | 0 | 4 |
_aStaphylococcus aureus _xdrug effects |
650 | 0 | 4 |
_aTriclosan _xpharmacology |
700 | 1 | _aMerrell, D Scott | |
773 | 0 |
_tMicrobiologyOpen _gvol. 9 _gno. 4 _gp. e1005 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1002/mbo3.1005 _zAvailable from publisher's website |
999 |
_c30630249 _d30630249 |